Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method.
Sci Rep. 2019 Oct 29;9(1):15506. doi: 10.1038/s41598-019-51697-6.
Sci Rep. 2019.
PMID: 31664085
Free PMC article.
Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
Martín de la Fuente L, Malander S, Hartman L, Jönsson JM, Ebbesson A, Nilbert M, Måsbäck A, Hedenfalk I.
Martín de la Fuente L, et al.
Int J Gynecol Pathol. 2018 Mar;37(2):101-109. doi: 10.1097/PGP.0000000000000394.
Int J Gynecol Pathol. 2018.
PMID: 28481779
Free PMC article.
Item in Clipboard
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma.
Martin de la Fuente L, Westbom-Fremer S, Arildsen NS, Hartman L, Malander S, Kannisto P, Måsbäck A, Hedenfalk I.
Martin de la Fuente L, et al.
Virchows Arch. 2020 Jul;477(1):83-91. doi: 10.1007/s00428-020-02751-6. Epub 2020 Jan 24.
Virchows Arch. 2020.
PMID: 31980961
Free PMC article.
Item in Clipboard
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery.
Bååth M, Westbom-Fremer S, Martin de la Fuente L, Ebbesson A, Davis J, Malander S, Måsbäck A, Kannisto P, Hedenfalk I.
Bååth M, et al. Among authors: martin de la fuente l.
Mol Cell Oncol. 2020 Sep 5;7(6):1805094. doi: 10.1080/23723556.2020.1805094.
Mol Cell Oncol. 2020.
PMID: 33235906
Free PMC article.
Item in Clipboard
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer.
Bååth M, Jönsson JM, Westbom Fremer S, Martín de la Fuente L, Tran L, Malander S, Kannisto P, Måsbäck A, Honeth G, Hedenfalk I.
Bååth M, et al. Among authors: martin de la fuente l.
Genes (Basel). 2021 May 14;12(5):742. doi: 10.3390/genes12050742.
Genes (Basel). 2021.
PMID: 34069138
Free PMC article.
Item in Clipboard
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Hüttenhain R, Choi M, Martin de la Fuente L, Oehl K, Chang CY, Zimmermann AK, Malander S, Olsson H, Surinova S, Clough T, Heinzelmann-Schwarz V, Wild PJ, Dinulescu DM, Niméus E, Vitek O, Aebersold R.
Hüttenhain R, et al. Among authors: martin de la fuente l.
Mol Cell Proteomics. 2019 Sep;18(9):1836-1850. doi: 10.1074/mcp.RA118.001221. Epub 2019 Jul 9.
Mol Cell Proteomics. 2019.
PMID: 31289117
Free PMC article.
Item in Clipboard
Item in Clipboard
Cite
Cite